{
     "PMID": "27747481",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20170307",
     "LR": "20171031",
     "IS": "1573-6903 (Electronic) 0364-3190 (Linking)",
     "VI": "42",
     "IP": "2",
     "DP": "2017 Feb",
     "TI": "ConBr, A Lectin Purified from the Seeds of Canavalia brasiliensis, Protects Against Ischemia in Organotypic Culture of Rat Hippocampus: Potential Implication of Voltage-Gated Calcium Channels.",
     "PG": "347-359",
     "LID": "10.1007/s11064-016-2078-7 [doi]",
     "AB": "Lectins are proteins that bind cellular glycans and can modulate various neuronal functions. We have evaluated the neuroprotective effect of ConBr, a lectin purified from the seeds of Canavalia brasiliensis in a model of rat organotypic hippocampal cultures (OHCs) exposed to oxygen and glucose deprivation (OGD). OGD for 15 min followed by 24 h re-oxygenation significantly increased cell death, caused mitochondrial depolarization and increased reactive oxygen species (ROS) in CA1 region of OHCs. ConBr (0.1 mug/mL) added during the re-oxygenation period counteracted cell death, mitochondrial depolarization and overproduction of ROS induced by OGD. Moreover, ConBr restored the levels of Akt and ERK1 phosphorylation that were reduced by OGD. Modulation of intracellular Ca(2+) by ConBr was evaluated in isolated hippocampal neurons loaded with the fluorescent calcium dye Fluo-4/AM. ConBr (0.1 and 1 microg/mL) reduced by 25-30 % the Ca(2+) increment induced by 70 mM K(+). A sub effective concentration of ConBr (0.01 microg/mL) together with a sub effective concentration of the L-type calcium channel antagonist nifedipine (0.3 microM) conferred a synergic neuroprotective effect in OHCs subjected to OGD. In conclusion, ConBr provides OHCs neuroprotection against OGD. The mechanism was not fully addressed but it may involve modulation of L-type voltage-gated Ca(2+) channels by ConBr.",
     "FAU": [
          "Rieger, D K",
          "Navarro, E",
          "Buendia, I",
          "Parada, E",
          "Gonzalez-Lafuente, L",
          "Leon, R",
          "Costa, A P",
          "Heinrich, I A",
          "Nascimento, K S",
          "Cavada, B S",
          "Lopez, M G",
          "Egea, J",
          "Leal, R B"
     ],
     "AU": [
          "Rieger DK",
          "Navarro E",
          "Buendia I",
          "Parada E",
          "Gonzalez-Lafuente L",
          "Leon R",
          "Costa AP",
          "Heinrich IA",
          "Nascimento KS",
          "Cavada BS",
          "Lopez MG",
          "Egea J",
          "Leal RB"
     ],
     "AD": "Programa de Pos-graduacao em Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Florianopolis, SC, Brazil. Departamento de Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Florianopolis, SC, 88040-900, Brazil. Instituto Teofilo Hernando, Universidad Autonoma de Madrid, Madrid, Spain. Department of Pharmacology, School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain. Instituto de Investigacion Sanitaria, Servicio de Farmacologia Clinica, Hospital Universitario de la Princesa, Madrid, Spain. Instituto Teofilo Hernando, Universidad Autonoma de Madrid, Madrid, Spain. Department of Pharmacology, School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain. Instituto de Investigacion Sanitaria, Servicio de Farmacologia Clinica, Hospital Universitario de la Princesa, Madrid, Spain. Instituto Teofilo Hernando, Universidad Autonoma de Madrid, Madrid, Spain. Department of Pharmacology, School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain. Instituto de Investigacion Sanitaria, Servicio de Farmacologia Clinica, Hospital Universitario de la Princesa, Madrid, Spain. Instituto Teofilo Hernando, Universidad Autonoma de Madrid, Madrid, Spain. Department of Pharmacology, School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain. Instituto de Investigacion Sanitaria, Servicio de Farmacologia Clinica, Hospital Universitario de la Princesa, Madrid, Spain. Instituto Teofilo Hernando, Universidad Autonoma de Madrid, Madrid, Spain. Department of Pharmacology, School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain. Instituto de Investigacion Sanitaria, Servicio de Farmacologia Clinica, Hospital Universitario de la Princesa, Madrid, Spain. Departamento de Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Florianopolis, SC, 88040-900, Brazil. Programa de Pos-graduacao em Neurociencias, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Florianopolis, SC, Brazil. Departamento de Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Florianopolis, SC, 88040-900, Brazil. Programa de Pos-graduacao em Neurociencias, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Florianopolis, SC, Brazil. BioMolLab, Universidade Federal do Ceara, Fortaleza, CE, 60455-970, Brazil. BioMolLab, Universidade Federal do Ceara, Fortaleza, CE, 60455-970, Brazil. Instituto Teofilo Hernando, Universidad Autonoma de Madrid, Madrid, Spain. Department of Pharmacology, School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain. Instituto de Investigacion Sanitaria, Servicio de Farmacologia Clinica, Hospital Universitario de la Princesa, Madrid, Spain. Instituto Teofilo Hernando, Universidad Autonoma de Madrid, Madrid, Spain. javier.egea@inv.uam.es. Department of Pharmacology, School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain. javier.egea@inv.uam.es. Instituto de Investigacion Sanitaria, Servicio de Farmacologia Clinica, Hospital Universitario de la Princesa, Madrid, Spain. javier.egea@inv.uam.es. Programa de Pos-graduacao em Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Florianopolis, SC, Brazil. rbleal@gmail.com. Departamento de Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Florianopolis, SC, 88040-900, Brazil. rbleal@gmail.com. Programa de Pos-graduacao em Neurociencias, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Florianopolis, SC, Brazil. rbleal@gmail.com.",
     "AUID": [
          "ORCID: http://orcid.org/0000-0003-2536-6888"
     ],
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20161017",
     "PL": "United States",
     "TA": "Neurochem Res",
     "JT": "Neurochemical research",
     "JID": "7613461",
     "RN": [
          "0 (Calcium Channels)",
          "0 (Neuroprotective Agents)",
          "0 (Plant Lectins)",
          "0 (lectin, Canavalia)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Brain Ischemia/*metabolism/prevention & control",
          "Calcium Channels/*metabolism",
          "*Canavalia",
          "Cells, Cultured",
          "Dose-Response Relationship, Drug",
          "Hippocampus/drug effects/*metabolism",
          "Neurons/drug effects/metabolism",
          "Neuroprotective Agents/pharmacology/*therapeutic use",
          "Organ Culture Techniques",
          "Plant Lectins/isolation & purification/pharmacology/*therapeutic use",
          "Rats",
          "Rats, Sprague-Dawley",
          "Seeds"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "ConBr",
          "Lectin",
          "Neuroprotection",
          "Organotypic hippocampal cultures",
          "Oxygen and glucose deprivation (OGD)"
     ],
     "EDAT": "2016/10/18 06:00",
     "MHDA": "2017/03/08 06:00",
     "CRDT": [
          "2016/10/18 06:00"
     ],
     "PHST": [
          "2016/02/23 00:00 [received]",
          "2016/10/04 00:00 [accepted]",
          "2016/09/22 00:00 [revised]",
          "2016/10/18 06:00 [pubmed]",
          "2017/03/08 06:00 [medline]",
          "2016/10/18 06:00 [entrez]"
     ],
     "AID": [
          "10.1007/s11064-016-2078-7 [doi]",
          "10.1007/s11064-016-2078-7 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Neurochem Res. 2017 Feb;42(2):347-359. doi: 10.1007/s11064-016-2078-7. Epub 2016 Oct 17.",
     "term": "hippocampus"
}